Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 101–200 of 999
β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability
Ataga, K. I., Cappellini, M. D., & Rachmilewitz, E. A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06740.x · Cited by 183
Liem, R. I., Lanzkron, S., D. Coates, T., DeCastro, L., Desai, A. A., Ataga, K. I., Cohen, R. T., Haynes, J., Osunkwo, I., Lebensburger, J. D., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000916 · Cited by 182
Management of Sickle Cell Disease: A Review for Physician Education in Nigeria (Sub-Saharan Africa)
Adewoyin, A. S. (2015) · Anemia · doi:10.1155/2015/791498 · Cited by 181
Sildenafil in the treatment of pulmonary hypertension
Barnett, C. F., & Machado, R. F. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.4.411 · Cited by 180
Pulmonary Complications of Sickle Cell Disease
Miller, A. C., & Gladwin, M. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2082ci · Cited by 180
Self-citationSinger, S. T., Kuypers, F. A., Styles, L., Vichinsky, E. P., Foote, D., & Rosenfeld, H. (2006) · American Journal of Hematology · doi:10.1002/ajh.20640 · Cited by 141
Panepinto, J. A., Walters, M. C., Carreras, J., Marsh, J., Bredeson, C. N., Gale, R. P., Hale, G. A., Horan, J., Hows, J. M., Klein, J. P., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06592.x · Cited by 179
Sickle Cell Disease: New Opportunities and Challenges in Africa
Makani, J., Ofori-Acquah, S. F., Nnodu, O., Wonkam, A., & Ohene-Frempong, K. (2013) · The Scientific World Journal · doi:10.1155/2013/193252 · Cited by 175
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
Gordeuk, V. R., Castro, O. L., & Machado, R. F. (2016) · Blood · doi:10.1182/blood-2015-08-618561 · Cited by 177
Self-citationHachulla, E., Carpentier, P., Gressin, V., Diot, E., Allanore, Y., Sibilia, J., Launay, D., Mouthon, L., Jego, P., Cabane, J., et al. (2008) · Rheumatology · doi:10.1093/rheumatology/ken488 · Cited by 173
Nolan, V. G., Adewoye, A., Baldwin, C., Wang, L., Ma, Q., Wyszynski, D. F., Farrell, J. J., Sebastiani, P., Farrer, L. A., & Steinberg, M. H. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06074.x · Cited by 172
Acute Chest Syndrome in Children with Sickle Cell Disease
Jain, S., Bakshi, N., & Krishnamurti, L. (2017) · Pediatric Allergy, Immunology, and Pulmonology · doi:10.1089/ped.2017.0814 · Cited by 169
Hebbel, R. P. (2011) · American Journal of Hematology · doi:10.1002/ajh.21952 · Cited by 169
Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease
Mekontso Dessap, A., Leon, R., Habibi, A., Nzouakou, R., Roudot-Thoraval, F., Adnot, S., Godeau, B., Galacteros, F., Brun-Buisson, C., Brochard, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1606oc · Cited by 170
Hemoglobin sickle cell disease complications: a clinical study of 179 cases
Lionnet, F., Hammoudi, N., Stojanovic, K. S., Avellino, V., Grateau, G., Girot, R., & Haymann, J.-P. (2012) · Haematologica · doi:10.3324/haematol.2011.055202 · Cited by 172
Novelli, E. M., & Gladwin, M. T. (2016) · Chest · doi:10.1016/j.chest.2015.12.016 · Cited by 169
Self-citationde la Fuente, J., Dhedin, N., Koyama, T., Bernaudin, F., Kuentz, M., Karnik, L., Socié, G., Culos, K. A., Brodsky, R. A., DeBaun, M. R., et al. (2019) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2018.11.027 · Cited by 166
Cardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164
Self-citationSickle cell disease and nitric oxide: A paradigm shift?
Kyle Mack, A., & Kato, G. J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.01.010 · Cited by 163
A network model to predict the risk of death in sickle cell disease
Sebastiani, P., Nolan, V. G., Baldwin, C. T., Abad-Grau, M. M., Wang, L., Adewoye, A. H., McMahon, L. C., Farrer, L. A., Taylor, J. G., Kato, G. J., et al. (2007) · Blood · doi:10.1182/blood-2007-04-084921 · Cited by 161
Self-citationJosephson, C. D., Su, L. L., Hillyer, K. L., & Hillyer, C. D. (2007) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2006.11.003 · Cited by 160
Differences in the clinical and genotypic presentation of sickle cell disease around the world
Saraf, S. L., Molokie, R. E., Nouraie, M., Sable, C. A., Luchtman-Jones, L., Ensing, G. J., Campbell, A. D., Rana, S. R., Niu, X. M., Machado, R. F., et al. (2014) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.11.003 · Cited by 158
Self-citationRed blood cell dysfunction: a new player in cardiovascular disease
Pernow, J., Mahdi, A., Yang, J., & Zhou, Z. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz156 · Cited by 158
Windsant, I. C. V., Wit, N. C. J. D., Sertorio, J. T. C., van Bijnen, A. A. J. H. M., Ganushchak, Y. M., Heijmans, J. H., Tanus-Santos, J. E., Jacobs, M. J. H. M., Maessen, J. G., & Buurman, W. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00340 · Cited by 167
Hill, A., Rother, R. P., Wang, X., Morris, Jr., Quinn‐Senger, K., Kelly, R., Richards, S. J., Bessler, M., Bell, L., Hillmen, P., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08096.x · Cited by 158
Self-citationBiomarkers in sickle cell disease
Rees, D. C., & Gibson, J. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08961.x · Cited by 177
Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now
Hsieh, M. M., Fitzhugh, C. D., & Tisdale, J. F. (2011) · Blood · doi:10.1182/blood-2011-01-332510 · Cited by 152
Pulmonary Hypertension Is Associated With Reduced Patient Survival After Kidney Transplantation
Issa, N. S., Krowka, M. J., Griffin, M. D., Hickson, L. J., Stegall, M. D., & Cosio, F. G. (2008) · Transplantation · doi:10.1097/tp.0b013e318188d640 · Cited by 153
Wallace, K. L., & Linden, J. (2010) · Blood · doi:10.1182/blood-2010-06-290643 · Cited by 152
Pulmonary hypertension in sickle cell disease
Ataga, K. I., Sood, N., Gent, G. D., Kelly, E. A., Henderson, A. G., Jones, S., Strayhorn, D., Lail, A. E., Lieff, S., & Orringer, E. P. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.034 · Cited by 152
Cardenes, N., Corey, C., Geary, L., Jain, S., Zharikov, S., Barge, S., Novelli, E. M., & Shiva, S. (2014) · Blood · doi:10.1182/blood-2013-09-529420 · Cited by 150
Sachdev, V., Kato, G. J., Gibbs, J. S. R., Barst, R. J., Machado, R. F., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.032920 · Cited by 147
Self-citationSickle Cell Anemia and Its Phenotypes
Williams, T., & Thein, S. L. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021320 · Cited by 201
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Rubin, L. J., & Badesch, D. B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00009 · Cited by 156
Asthma is associated with Increased mortality in individuals with sickle cell anemia
Boyd, J. H., Macklin, E. A., Strunk, R. C., & DeBaun, M. R. (2007) · Haematologica · doi:10.3324/haematol.11213 · Cited by 145
Pulmonary Hypertension Surveillance
George, M. G., Schieb, L. J., Ayala, C., Talwalkar, A., & Levant, S. (2014) · Chest · doi:10.1378/chest.14-0527 · Cited by 144
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
Niss, O., Quinn, C. T., Lane, A., Daily, J., Khoury, P. R., Bakeer, N., Kimball, T. R., Towbin, J. A., Malik, P., & Taylor, M. D. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.05.013 · Cited by 142
Early detection of pulmonary arterial hypertension
Lau, E., Humbert, M. J. C., & Celermajer, D. S. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.191 · Cited by 158
Raghavachari, N., Xu, X., Harris, A. B., Villagra, J. D., Logun, C., Barb, J. J., Solomon, M. A., Suffredini, A. F., Danner, R. L., Kato, G. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.658641 · Cited by 146
Self-citationNoubouossie, D. F., Key, N. S., & Ataga, K. I. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.12.003 · Cited by 149
Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria
Hill, A., Richards, S. J., & Hillmen, P. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06554.x · Cited by 152
Maitra, P., Caughey, M., Robinson, L., Desai, P. C., Jones, S., Nouraie, M., Gladwin, M. T., Hinderliter, A., Cai, J., & Ataga, K. I. (2017) · Haematologica · doi:10.3324/haematol.2016.153791 · Cited by 137
Self-citationGenetic modifiers of the β‐haemoglobinopathies
Thein, S. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07084.x · Cited by 137
Recommandations françaises de prise en charge de la drépanocytose de l'adulte : actualisation 2015
Habibi, A., Arlet, J. B., Stankovic, K., Gellen‐Dautremer, J., Ribeil, J., Bartolucci, P., & Lionnet, F. (2015) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(15)60002-9 · Cited by 149
Transfusion therapy for sickle cell disease: a balancing act
Chou, S. T. (2013) · Hematology · doi:10.1182/asheducation-2013.1.439 · Cited by 154
Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease
Mehari, A., Alam, S., Tian, X., Cuttica, M. J., Barnett, C. F., Miles, G., Xu, D., Seamon, C., Adams-Graves, P., Castro, O. L., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1222oc · Cited by 135
Self-citationDarbari, D. S., Wang, Z., Kwak, M., Hildesheim, M. E., Nichols, J., Allen, D. T., Seamon, C. A., Peters-Lawrence, M. H., Conrey, A. K., Hall, M. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079923 · Cited by 138
Self-citationGordeuk, V. R., Sachdev, V., Taylor, J. G., Gladwin, M. T., Kato, G., & Castro, O. L. (2008) · American Journal of Hematology · doi:10.1002/ajh.21016 · Cited by 136
Self-citationVasculopathy and pulmonary hypertension in sickle cell disease
Potoka, K. P., & Gladwin, M. T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2014 · Cited by 133
Self-citationBarst, R. J., Mubarak, K. K., Machado, R. F., Ataga, K. I., Benza, R. L., Castro, O. L., Naeije, R., Sood, N., Swerdlow, P. S., Hildesheim, M. E., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08097.x · Cited by 136
Self-citationGladwin, M. T., Barst, R. J., Gibbs, J. S. R., Hildesheim, M., Sachdev, V., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099489 · Cited by 132
Self-citationYeo, T. W., Lampah, D. A., Tjitra, E., Gitawati, R., Kenangalem, E., Piera, K., Granger, D. L., Lopansri, B. K., Weinberg, J. B., Price, R. N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/644641 · Cited by 132
Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension
Thistlethwaite, P. A., Kemp, A., Du, L., Madani, M. M., & Jamieson, S. W. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.07.033 · Cited by 131
Buchanan, G. R., DeBaun, M. R., Quinn, C. T., & Steinberg, M. H. (2004) · Hematology · doi:10.1182/asheducation-2004.1.35 · Cited by 115
Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis
Gladwin, M. T., & Kim-Shapiro, D. B. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833157f4 · Cited by 128
Self-citationWalters, M. C., De Castro, L. M., Sullivan, K. M., Krishnamurti, L., Kamani, N., Bredeson, C., Neuberg, D., Hassell, K. L., Farnia, S., Campbell, A., et al. (2016) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2015.10.017 · Cited by 128
Minireview: Genetic basis of heterogeneity and severity in sickle cell disease
Habara, A. H., & Steinberg, M. H. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216636726 · Cited by 152
Kanter, J., Thompson, A. A., Pierciey, F. J., Hsieh, M., Uchida, N., Leboulch, P., Schmidt, M., Bonner, M., Guo, R., Miller, A., et al. (2023) · American Journal of Hematology · doi:10.1002/ajh.26741 · Cited by 134
Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension
Hsue, P. Y., Deeks, S. G., Farah, H. H., Palav, S., Ahmed, S. Y., Schnell, A., Ellman, A. B., Huang, L., Dollard, S. C., & Martin, J. N. (2008) · AIDS · doi:10.1097/qad.0b013e3282f7cd42 · Cited by 127
Anxiety and depression in children and adolescents with sickle cell disease
Benton, T. D., Ifeagwu, J. A., & Smith‐Whitley, K. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0080-0 · Cited by 141
Haemolysis and abnormal haemorheology in sickle cell anaemia
Connes, P., Lamarre, Y., Waltz, X., Ballas, S. K., Lemonne, N., Etienne-Julan, M., Hue, O., Hardy-Dessources, M.-D., & Romana, M. (2014) · British Journal of Haematology · doi:10.1111/bjh.12786 · Cited by 125
Huston, J., Maron, B. A., French, J. K., Huang, S., Thayer, T. E., Farber‐Eger, E. H., Wells, Q. S., Choudhary, G., Hemnes, A. R., & Brittain, E. L. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3345 · Cited by 130
Machado, R. F., & Gladwin, M. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05432.x · Cited by 128
Self-citationDerchi, G., Forni, G. L., Formisano, F., Cappellini, Galanello, R., D'Ascola, G., Bina, P., Magnano, C., & Lamagna, M. (2005) · PubMed · Cited by 125
Association between hemolysis and albuminuria in adults with sickle cell anemia
Day, T. G., Drasar, E. R., Fulford, T., Sharpe, C. C., & Thein, S. L. (2012) · Haematologica · doi:10.3324/haematol.2011.050336 · Cited by 126
Machado, R. F., Kyle Mack, A., Martyr, S., Barnett, C., MacArthur, P., Sachdev, V., Ernst, I., Hunter, L. A., Coles, W. A., Nichols, J. P., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06417.x · Cited by 122
Self-citationInhaled Nitric Oxide Enables Artificial Blood Transfusion Without Hypertension
Yu, B., Raher, M. J., Volpato, G. P., Bloch, K. D., Ichinose, F., & Zapol, W. M. (2008) · Circulation · doi:10.1161/circulationaha.107.729137 · Cited by 120
Zhou, Z., Han, H., Crúz, M. A., López, J. A., Dong, J.-F., & Guchhait, P. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0677 · Cited by 123
Coagulation and Splenectomy: An Overview
Cappellini, M. D., Grespi, E., Cassinerio, E., Bignamini, D., & Fiorelli, G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.039 · Cited by 119
Sickle cell anemia and vascular dysfunction: The nitric oxide connection
Akinsheye, I., & Klings, E. S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22195 · Cited by 120
Sickle Cell Disease in Childhood
Quinn, C. T. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2013.09.006 · Cited by 135
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD
Navaneethan, S. D., Roy, J., Tao, K., Brecklin, C. S., Chen, J., Deo, R., Flack, J. M., OJO, A. O., Plappert, T. J., Raj, D. S., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111111 · Cited by 119
Quinn, C. T. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216640385 · Cited by 136
The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease
Gbotosho, O. T., Kapetanaki, M. G., & Kato, G. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.561917 · Cited by 136
Morris, C. R., Gladwin, M. T., & Kato, G. J. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241447 · Cited by 124
Self-citationAssociation between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia
Niss, O., Fleck, R., Makue, F., Alsaied, T., Desai, P., Towbin, J. A., Malik, P., Taylor, M. D., & Quinn, C. T. (2017) · Blood · doi:10.1182/blood-2017-02-767624 · Cited by 115
Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine
Kale, A., Rogers, N. M., & Ghimire, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084062 · Cited by 127
Beigi, A. A., Sadeghi, A. M. M., Khosravi, A., Karami, M., & Masoudpour, H. (2009) · The Journal of Vascular Access · doi:10.1177/112972980901000305 · Cited by 114
Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia
Connes, P., Machado, R. F., Hüe, O., & Reid, H. L. (2011) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2011-1465 · Cited by 124
Erythroid DAMPs drive inflammation in SCD
Gladwin, M. T., & Ofori-Acquah, S. F. (2014) · Blood · doi:10.1182/blood-2014-03-563874 · Cited by 113
Self-citationBallas, S. K., & Marcolina, M. J. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00679.x · Cited by 114
Sickle Cell Disease, Vasculopathy, and Therapeutics
Kassim, A. A., & DeBaun, M. R. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-120611-143127 · Cited by 122
Erythrocyte Hemolysis and Hemoglobin Oxidation Promote Ferric Chloride-induced Vascular Injury
Woollard, K. J., Sturgeon, S., Chin-Dusting, J. P. F., Salem, H. H., & Jackson, S. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809095200 · Cited by 112
Hemolysis‐Associated Pulmonary Hypertension in Thalassemia
MORRIS, C. R., KUYPERS, F. A., KATO, G. J., LAVRISHA, L., LARKIN, S., SINGER, T., & VICHINSKY, E. P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.058 · Cited by 112
Ambrusko, S. J., Gunawardena, S. W., Sakara, A., Windsor, B., Lanford, L. M., Michelson, P. H., & Krishnamurti, L. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20791 · Cited by 115
Pashankar, F. D., Carbonella, J., Bazzy-Asaad, A., & Friedman, A. (2008) · Pediatrics · doi:10.1542/peds.2007-0730 · Cited by 111
Pulmonary Vascular Disease in the Developing World
BUTROUS, G. S., Ghofrani, H. A., & Grimminger, F. (2008) · Circulation · doi:10.1161/circulationaha.107.727289 · Cited by 115
Cardiopulmonary Complications of Sickle Cell Disease: Role of Nitric Oxide and Hemolytic Anemia
Gladwin, M. T., & Kato, G. J. (2005) · Hematology · doi:10.1182/asheducation-2005.1.51 · Cited by 111
Self-citationAbassi, Z. A., Nakhoul, F. M., Khankin, E. V., Reisner, S. A., & Yigla, M. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000232874.27846.37 · Cited by 110
Aliyu, Z. Y., Kato, G. J., Taylor, J. G., Babadoko, A., Mamman, A. I., Gordeuk, V. R., & Gladwin, M. T. (2007) · American Journal of Hematology · doi:10.1002/ajh.21057 · Cited by 127
Self-citationHeart failure in β-thalassemia syndromes: A decade of progress
Hahalis, G. N., Alexopoulos, D., Kremastinos, D. T., & Zoumbos, N. C. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.021 · Cited by 134
PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to Children
Kato, G. J., Onyekwere, O. C., & Gladwin, M. T. (2007) · Pediatric Hematology and Oncology · doi:10.1080/08880010601185892 · Cited by 110
Self-citationBhatia, M., Jin, Z., Baker, C., Geyer, M. B., Radhakrishnan, K., Morris, E., Satwani, P., George, D., Garvin, J. H., del Toro, G., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.84 · Cited by 114
Barnett, C. F., Hsue, P. Y., & Machado, R. F. (2008) · JAMA · doi:10.1001/jama.299.3.324 · Cited by 117
Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis
Schaer, C. A., Deuel, J., Schildknecht, D., Mahmoudi, L., García‐Rubio, I., Owczarek, C. M., Schauer, S., Kissner, R., Banerjee, U., Palmer, A. F., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2058oc · Cited by 113
McGann, P. T., Niss, O., Dong, M., Marahatta, A., Howard, T. A., Mizuno, T., Lane, A., Kalfa, T. A., Malik, P., Quinn, C. T., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25510 · Cited by 105
Fitzhugh, C. D., Hsieh, M. M., Taylor, T., Coles, W., Roskom, K., Wilson, D., Wright, E., Jeffries, N., Gamper, C. J., Powell, J., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002972 · Cited by 105
Self-citationLack of a Tricuspid Regurgitation Doppler Signal and Pulmonary Hypertension by Invasive Measurement
O'Leary, J. M., Assad, T. R., Xu, M., Farber‐Eger, E., Wells, Q. S., Hemnes, A. R., & Brittain, E. L. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009362 · Cited by 103
Aliyu, Z. Y., Gordeuk, V., Sachdev, V., Babadoko, A., Mamman, A. I., Akpanpe, P., Attah, E., Suleiman, Y., Aliyu, N., Yusuf, J., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21162 · Cited by 105
Self-citationHill, A., Sapsford, R. J., Scally, A., Kelly, R., Richards, S. J., Khurisgara, G., Sivananthan, M. U., & Hillmen, P. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09166.x · Cited by 104
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.